GMED Globus Medical Inc - Class A

  1. Stocks
  2. Healthcare
  3. NYSE: GMED

Price (delayed)

$86.91

Market cap

$11.67B

P/E Ratio

21.89

Dividend/share

N/A

EPS

$3.97

Enterprise value

$11.27B

?
Relative Growth: Rel. Growth: 97
Relative Strength: Rel. Strength: 51
Relative Valuation: Rel. Valuation: 69
Relative Profitability: Rel. Profitability: 88

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing ...

Highlights
GMED's quick ratio is up by 36% year-on-year
The gross profit has grown by 31% YoY and by 2.5% from the previous quarter
The P/E is 62% less than the 5-year quarterly average of 57.0 but 9% more than the last 4 quarters average of 20.0
The EPS has surged by 51% year-on-year but it has declined by 9% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.globusmedical.com
Peers: SYK OFIX ATEC

Key stats

What are the main financial stats of GMED

GMED stock price

How has the Globus Medical Inc - Class A stock price performed over time
Intraday
1.45%
1 week
1.18%
1 month
14.22%
1 year
43.65%
YTD
-0.46%
QTD
10%

Financial performance

How have Globus Medical Inc - Class A's revenue and profit performed over time
Revenue
$3.14B
Gross profit
$2.16B
Operating income
$639.52M
Net income
$535.43M
Gross margin
68.5%
Net margin
17%
The operating income has soared by 127% YoY and by 20% QoQ
The company's operating margin has surged by 90% YoY and by 18% QoQ
The company's net income has surged by 50% YoY but it fell by 9% QoQ
The gross profit has grown by 31% YoY and by 2.5% from the previous quarter

Price vs fundamentals

How does GMED's price correlate with its fundamentals

Growth

What is Globus Medical Inc - Class A's growth rate over time

Valuation

What is Globus Medical Inc - Class A stock price valuation
GMED P/E details
P/E
21.89
P/B
2.47
P/S
3.73
EV/EBIT
17.53
EV/EBITDA
12.22
EV/Sales
3.58
The P/E is 62% less than the 5-year quarterly average of 57.0 but 9% more than the last 4 quarters average of 20.0
The EPS has surged by 51% year-on-year but it has declined by 9% since the previous quarter
The stock's P/B is 12% less than its 5-year quarterly average of 2.8 but 7% more than its last 4 quarters average of 2.3
GMED's equity is up by 11% year-on-year
GMED's P/S is 25% lower than its 5-year quarterly average of 5.0 but 7% higher than its last 4 quarters average of 3.5
Globus Medical Inc - Class A's revenue has increased by 20% YoY

Efficiency

How efficient is Globus Medical Inc - Class A business performance
GMED's ROIC is up by 46% year-on-year but it is down by 3.8% since the previous quarter
The return on sales has grown by 45% year-on-year but it has declined by 2.4% since the previous quarter
The ROA is up by 41% year-on-year but it is down by 12% since the previous quarter
Globus Medical Inc - Class A's return on equity has increased by 35% YoY but it has decreased by 11% QoQ

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical Inc - Class A financials performed over time
GMED's quick ratio is up by 36% year-on-year
Globus Medical Inc - Class A's current ratio has increased by 14% YoY
The debt is 98% smaller than the equity
The company's debt to equity fell by 33% YoY
GMED's equity is up by 11% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.